Back issues are available for $3.00 each. Subscriptions are available for $20 per year. To order, please send a check (payable to Public Citizen) to Health Research Group, 1600 20th Street NW, Washington, DC 20009, or you can order by phone with a major credit card at 202 588-1000.
July 2001, V7#7
The Diabetes Drug Metformin (GLUCOPHAGE) and Lactic Acidosis--A Reminder About a Potentially Fatal Adverse Drug Reaction
Do Not Use: Oral Itraconazole (LAMISIL) for Fungal Nail Infections
Last Choice Drug--Doxazosin (CARDURA) For High Blood Pressure
Reduction In Cancer Risk Claim for Antioxidant Vitamins Rejected by the Food and Drug Administration (FDA)
June 2001, V7#6
Do Not Use: Ziprasidone (GEODON)--A New, More Dangerous, Less Effective Antipsychotic Drug
Yet Another Drug Safety Withdrawal: Raplon
New Warnings: Linezolid (ZYVOX)--The First Member of a New Class of Antibiotics
May 2001, V7#5
Review of Drugs for High Blood Pressure including: angiotensin converting enzyme inhibitors; angiotension receptor antagonists; beta blockers; diuretics; calcium channel blockers; alpha blockers; central alpha adrenergic agonists; direct vasodilators and; peripheral adrenergic neuron antagonists.
April 2001, V7#4
Review of Beta-blockers--Atenolol (TENORMIN), Propranolol (INDERAL) and Many Others
Do Not Use: Celecoxib (CELEBREX) and Rofecoxib (VIOXX) for Arthritis--The Misnamed and Overpriced "Super Aspirins"
Do Not Use: Adulterated Chinese Herbal Anso Comfort Capsules
Rapid Heart Rate With the Fluroquinolone Antibiotic Moxifloxacin (AVELOX)
FDA Finds Lack of Conclusive Evidence that Vitamin E Supplements Reduce the Risk of Cardiovascular Disease
March 2001, V7#3
Food and Drug Administration (FDA) Issues Urgent Recall of Injectable Drugs
New Safety Warning For the Alzheimer’s Disease Drug Rivastigmine (EXELON)
The Italian Drug Glucosamine (XICIL) In the Treatment of Osteoarthritis
Major Breakthroughs In the Prevention and Treatment of High Blood Pressure
Review of Anti-Seizure Drugs for Bipolar Disorder
February 2001, V7#2
Postmenopausal Estrogen Replacement Therapy: Is its Value Exaggerated and Its Role Vanishing?
Sever Liver Injury with the Asthma Drug Zafirlukast (ACCOLATE)
A Statistical Summary: Treatment of Schizophrenia With Newer Antipsychotic Drugs
Kidney-toxic and Cancer Causing Chinese Herbal Supplements are Recalled
Ginkgo Biloba is Found Ineffective for Dementia and Age-Associated Memory Impairment in the Elderly
January 2001, V7#1
Irritable Bowel Syndrome Drug Alosetron (LOTRONEX) Withdrawn From the Market
Do Not Use Before April 2005 - Rivastigmine (EXELON) - A Third Drug for Alzheimer's Disease
Older Adults Not Getting the Most Effective Drugs for High Blood Pressure
FDA Safety Office Recommends Warning About Liver Failure with the Cholesterol Lowering "Statin" Drugs
December 2000, V6#12
Public Citizen Petitions to Ban All Uses of Phenylpropanolamine (PPA) in Over-the-Counter (OTC) Drug Products
How You Can Report Adverse Reactions to the Food and Drug Administration
Additional Warnings Are Added to Labeling for the Arthritis Drug Etanercept (ENBREL)
NIH Stops Trial of Calcium Channel Blocker Amlodipine (NORVASX) in Treatment of High Blood Pressure Patients with Kidney Disease
Do Not Use! Increasing Reports of Ischemic Colitis with the Irritable Bowel Syndrome Drug Alosetron (LOTRONEX)
Penciclovir (Denavir) Cream: Expensive Treatment for Cold Sores
November 2000, V6#11
Oral Prescription Drugs with Black Box Warnings: A List of 90 Drugs
Review of Adverse Drug Reaction Reports for the Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants in the United Kingdom
Update from the United Kingdom on Adverse Drug Reactions Reported for the Arthritis Drug Rofecoxib (VIOXX)
October 2000, V6#10
Long-acting Calcium Channel Blockers Inferior to Older Blood Pressure Lowering Drugs in Preventing Heart Attacks and Heart Failure
Do Not Use! Combination of Betamethasone and Clotrimazole (LOTRISONE CREAM) Especially in Children Under 12 or For Diaper Rash
Review of Calcium Supplements: Ads Exaggerate Differences
Victimizing the Vulnerable--Health Food Store Recommendations for Breast Cancer Patients
September 2000, V6#9
Do Not Use! The Antipsychotic Drug Thioridazine (MELLARIL)
Do Not Use! Stroke Risk Reported With the Nonprescription Diet Drug and Nasal Decongestant Phenylpropanolamine (DEXATRIM)
New Warnings about Zanamivir (RELENZA)
Important Drug Warning! Life-threatening Inflammationof the Pancreas with Divalproex (DEPAKOTE) and Valproic Acid (DEPAKENE)
August 2000, V6#8
-Erroneous and Misleading Reports in Media About Prescription Drugs
-Do Not Use!--Alosetron (LOTRONEX) for the Treatment of Irritable Bowel Syndrome In Women
-Drug-Induced Stuttering
-Important Changes in Safety Labeling of Acne Drug Isotretinoin (ACCUTANE)
-Prescription Drug Dispensing Errors Alert Lamotrigine (LAMICTAL) Tablets and Terbinafine (LAMISIL)
July 2000, Vol.6#7
-Do Not Use! Meloxicam (MOBIC) Nonsteroidal Anti-inflammatory Drugs
-Case Report: Why We List The Muscle Relaxant Cyclobenzaprine (FLEXERIL) As A "Do Not Use" Drug
-Postmenopausal Hormone Replacement Linked to Increased Risk of Blood Clots
-More Reports of Serious Drug Interactions Between St. John's Wort and the Anti-organ Rejection Drug Cyclosporine (NEORAL, SANDIMMUNE)
-Warning! Do Not Use! Chinese Herbal Supplements Containing Aristolochic Acid
June 2000, Vol.6#6
-Dangerous Gap in Drug Safety System; Drug Companies May Be Failing to Keep Their Post-marketing Research Promises
-Canadian Update on the Drug Celecoxcib (CELEBREX) Confirms HRG Warning
-'Gold Standard' Study Shows No Detectable Benefit Derived From Coensyme Q10 For Congestive Heart Failure
-Shoddy Manufacturing and Labeling Practices Found in Dietary Supplements Containing Ephedra
-Life-Threatening Blood Disorder Associated With Use of Clopidogrel (PLAVIX)
-eLetter Web Site Launched on Drugs for the Seriously Mentally Ill
May 2000, Vol.6#5
-Six Drug Withdrawals In 30 Months on Safety Grounds; Why the Five-Year Rule is More Important than Ever
-Dangerous Heartburn Drug Cisapride (PROPULSID) Withdrawn But Remains Available
-The Long Overdue Withdrawal of the Diabetes Drug Troglitazone (REZULIN)
-New Recommendations on the Use of the Alpha-blockers Doxazosin (CARDURA), Prazosin (MINIPRESS), Terazosin (HYTRIN) in the Treatment of High Blood Pressure
April 2000, Vol.6#4
-Liver Toxicity Reproted With the New Diabetes Drug Rosiglitazone (AVANDIA)
-Save Your Money: Do Not Use Vitamin E for Preventing Heart Attack and Stroke
-New Drug Interaction Warnings for the Antifungal Drug Itraconazole (SPORANOX)
-California Health Director Warns Consumers About Prescription Drugs in Herbal Products
-Update on Adverse Effects: Bupropion (ZYBAN) for Smoking Cessation
March 2000, Vol.6#3
-Health Hazard! "Wilson’s Syndrome" - Quackery and Pharmaceutical Trickery (Pharmacy Compounding)
-70 Deaths Now Linked to the Dangerous Heartburn Drug Cisapride (PROPULSID)
-The United Kingdom Prospective Diabetes Study (UKPDS) - Reducing Long-Term Complications of Type-2 Diabetes
February 2000, Vol.6#2
-Do Not Use: Moxifloxacin (Avelox) - The Ninth Fluoroquinolone Antibiotic
-Hypericum Extract (from St. John’s Wort) in the Treatment of Moderate Depression
-Further Evaluation of the Flu Drug Zanamivir (RELENZA)
January 2000, Vol.6#1
-Do Not Use! Oseltamivir (Tamiflu): Another Expensive New Flu Drug
-Do Not Use Until November 2004: Rabeprazole (Aciphex) - The Third Proton-Pump Inhibitor
-Update on Sildenafil (Viagra) For Sexual Dysfunction
-New Research on Direct-to-Consumer Prescription Drug Advertising
-Ineffective and Dangerous Dietary Supplements: S-adenosyl-methionine (SAMe) For Depression and the Diet Pill Tiratricol (Triax)
-Update on European Regulators and Diet Drugs: Sibutramine (Meridia) Hits a Snag
December 1999, Vol. 5#12
-Where is Congress? Antibiotic Grepafloxacin (RAXAR) Withdrawn from Market - Fourth Drug in Two Years
-Rotavirus Vaccine (ROTASHIELD) Withdrawn From the Market
-Reducing the Risk of Type-2 Diabetes in Women
-The New Diabetes Drug Rosiglitazone (AVANDIA) Rejected by European Regulators
-Amphetamine-like Diet Drugs Recommended to be Withdrawn in Europe: Do Not Use Diethylpropion (TENUATE), Phendimetrazine (BONTRIL, PRELU-2), and Phentermine (ADIPEX-P, FASTIN, IONAMINE)
November 1999, Vol. 5#11
-Do Not Use! Zanamivir (RELENZA) for the Flu - Cost Without Benefit
-Plain Aspirin is Preferred over Clopidogrel (PLAVIX) in Preventing Stroke, Heart Attack, and Blood Clots
-Update: Parkinson Drug Pramipexole (MIRAPEX) and Sudden Onset of Sleep
-New Drug Interaction Warnings! Sudden Deaths Reported with Pimozide (ORAP)
-New Adverse Reaction Warning: Liver Toxicity with the Prostrate Cancer Drug Flutamide
October 1999, Vol. 5#10
-High Level of Inappropriate Prescribing for the Elderly Continues to Be Noted
-Fluoroquinolone Antibiotics (CIPRO and Others) are Linked to Tendinitis and Tendon Rupture
-FDA Bans Alternative Medicine Treatments Containing Silver as Worthless
-More Serious Reactions and Deaths Associated with Dietary Supplements Containing GBL, GHB, or BD
-Potential Health Hazard! Wyeth-Ayerst Labs Recall Allergic Reaction Kits
-Fish Oil Protects Against Second Heart Attack but Vitamin E Does Not, Italian Study Reveals
September 1999, Vol. 5#9
-New Research Finding! Tried-and-True ‘Water Pill’ Found to Reduce Risk of Death or Hospitalization in Patients with Severe Heart Failure
-Do Not Use! Levalbuterol (XOPENEX) for the Treatment of Asthma
-Unhappy with CDC Declaration on Its High-Priced Antibiotic, Pfizer Launches a High-Powered Misinformation Campaign
-Safety Update on the Alzheimer’s Disease Drug Donepezil (ARICEPT)
-Sudden Sleep Onset with Two Parkinson’s Disease Drugs Pramipexole (MIRAPEX) and Ropinirole (REQUIP)
August 1999, Vol. 5#8
-The Long Overdue Withdrawal of the Dangerous Antihistamine Astemizole (HISMANAL) from the Market
-Stronger Warnings About Life-Threatening Liver Toxicity with Pemoline (CYLERT): Do Not Use
-Warning! Deaths Reported With the Unregulated Dietary Supplement 1,4 Butanediol (BD)
-More Warnings About Liver Toxicity with the Diabetes Drug Troglitazone (REZULIN): Do Not Use
July 1999, Vol. 5#7
-Do Not Use! The Fluroquinolone Antibiotic Trovafloxacin (TROVAN) Linked to Life-threatening Liver Toxicity
-Do Not Use Before July 2004: Rofecoxib (VIOXX) - One More Nonsteroidal Anti-Inflammatory Drug (NSAID) on the Market
-New Warning! Serious Infections and Deaths from the Arthritis Drug Etanercept (ENBREL)
-New Warning! Increased Risk of Bleeding with Celecoxib (CELEBREX) and Warfarin (COUMADIN)
-Dangerous Drug Information on the Internet from Aetna and Johns Hopkins
June 1999, Vol. 5 #6
-Health Research Group Petitions the FDA to Revise Labeling on the Breast Cancer Drug Tamoxifen (NOLVADEX)
-Update on the Nonsteroidal Anti-inflammatory Drug Celecoxib (Celebrex)
-Do Not Use Until May 2003: Tolterodine (DETROL) -- Another Drug for Urinary Incontinence
-Do Not Use! Orlistat (XENICAL) -- Another Diet Drug
May 1999, Vol. 5 #5
-Do Not Use! Cilostazol (PLETAL) for Intermittent Claudication
-The Troglitazone (REZULIN) Safety Meeting
-Do Not Use! Oral Contraceptives Containing Desogestrel with Ethinyl Estradiol (DESOGEN, ORTHO-CEPT)
-Part 6: A Review of Drug-Induced Psychiatric Effects
-Medicare Must Cover Prescription Drugs and Control Prices
April 1999, Vol. 5 #4
-Do Not Use Until February 2004: Celecoxib (CELEBREX) --Another Nonsteroidal Anti-Inflammatory Drug (NSAID)
-The Safety and Effectiveness of Homeopathic Drugs
-Part 5: A Review of Drug-induced Psychiatric Effects
-Preventing Osteoporosis, Falls and Fractures in Older Adults
-The Poor Quality of Some Melatonin Products
March 1999, Vol. 5 #3
-The New Edition of Worst Pills, Best Pills
-Consumer Alert! False and Misleading Claims for Raloxifene (Evista) by Eli Lilly and Company
-Do Not Use Until October 2003 Citalopram (Celexa) --Another Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressant
-Part 4: A Review of Drug-Induced Psychiatric Effects
-Public Citizen in the Courts: Health Research Group Sues the FDA Over Access to Drug Information
-FDA Warns About Products Containing Gamma Butyrolactone (GBL)
February 1999, Vol. 5 #2
-New Research: Who Benefits and How Much with Alendronate (Fosamax)?
-New Adverse Reaction Warning for the Asthman Drug Montelukast (Singulair)
-Part 3: A Review of Drug-Induced Psychiatric Effects
-Do Not Use Until 2004: Cefdinir -- Another Oral Antibiotic
January 1999, Vol. 5 #1
-Dangerous and Illegal Promotion of the Heartburn Drug Cisapride (Propulsid)
-Do Not Use! New Warning - Fatal Liver Toxicity with Parkinson Drug Tolcapone (Tasmar)
-Review of Drug-Induced Psychiatric Effects: Part 2
-FDA Medical Officers Report Lower Standards Permit Dangerous Drug Approvals
-Worst Pills Best Pills News Subject/Volume Index
December 1998, Vol. 4 #12
-FDA’s Controversial Decision: Tamoxifen (Nolvadex) Approved to Reduce the Risk of Breast Cancer
-New Adverse Reaction Warning! Antibiotic Trovafloxacin (Torvan) Linked to Liver Toxicity
-A New Series (Part 1) Review of Drug-Induced Psychiatric Effects
-Alcohol, Painkillers Don’t Mix: FDA Orders Warnings for Over-the-Counter Pain Relievers and Fever Reducers
November 1998, Vol. 4 #11
-Pharmacy Compounding: A Dangerous Double Drug Standard
-Estrogen Replacement Therapy
-Untested "Alternative Medicine" Remedies
-The A-B-Cs of Vitamins
October 1998, Vol. 4 #10
-Fenofibrate (Tricor), Medication to Lower Fat Levels in the Blood
-Do Not Use Before February 2003 Montelukast (Singulair) - 3rd Leukotriene Modifier for Asthma
-Do Not Use! Phendimetrazine (Plegine) - Reports of Heart Valve Damage and Primary Pulmonary Hypertension (PPH)
-Adverse Drug Reaction Alert! Stronger Warnings for Ticlopidine (Ticlid)
-Merck Drug, Mark McGwire and Barbecue
-FDA Confirms Impurities in the Dietary Supplement 5-Hydroxy-L-tryptophan
September 1998, Vol. 4 #9
-How to Report Adverse Reactions and Other Problems to the Food and Drug Administration
-Public Citizen Petitions the FDA to Ban Diabetes Drug Troglitazone (Rezulin)
-LifeScan Inc.’s SureStep Blood Glucose Meters Recalled
August 1998, Vol. 4 #8
-A Cure for Stomach Ulcers 70 to 90 Percent of the Time
-Do Not Use: The Nighttime Heartburn Drug Cisapride (Propulsid)
-Public Citizen’s Health Research Group Petitions the FDA About Sildenafil (Viagra)
-What We Know About Garlic For Cholesterol-Lowering
-Bromfenac (Duract) Banned: Third New Drug Withdrawal in Nine Months Suggests FDA’s Approval System is Breaking Down
-Don’t Be a Casualty on the Information Super Highway
July 1998, Vol. 4 #7
-Dangerous Heart Drug Withdrawn From the Market (Posicor)
-Do Not Use: Repaglinide (Prandin) Another Drug for Type 2 Diabetes
-Do Not Use Before 2004 (Five Years After Release) Sildenafil (Viagra) for Male Sexual Dysfunction
June 1998, Vol. 4 #6
-Liver Toxicity With Diabetes Drug Acarbose (Precose)
-Warning: More Serious Problems with Ticlopidine (Ticlid)
-Review: Part 9: Interactions of the Most Frequently Prescribed Drugs
-Melatonin and Increased Seizures in Disabled Children
-Public Citizen Petitions the FDA to Stop Distribution of Misleading Drug Information
May 1998, Vol. 4 #5
-Do Not Use! Bromfenac (Duract): New Warnings About Liver Toxicity
-The Five-Year Rule: Wait at Least Until October 2002 to Take this Product: Irbesartan (Avapro) - Another High Blood Pressure Drug
-New Drug Interaction Warning! Actaminophen (Tylenol) with Warfarin (Coumadin)
-Where Do Doctors Get Their Information About Blood Pressure Lowering Drugs?
-Reducing Your Drug Bill
-Review: Part 8: Interactions of the Most Frequently Prescribed Drugs
April 1998, Vol. 4 #4
-Do Not Use! The Deja Vu Diet Drug Sibutramine (Meridia)
-Do Not Use! Bromfenac (Duract): New Warnings About Liver Toxicity
-Warning! More Cases of Liver Toxicity With Troglitazone (Rezulin)
-Grepafloxacin (Raxar), The Eight Flouroquinolone Antibiotic: Do Not Use (Who Needs It?)
-Review: Part 7, Interactions of the Most Frequently Prescribed Drugs
March 1998, Vol. 4 #3
-Wait Five Years to Take Cerivastatin (Baycol) - The Sixth "Statin"
-Drug Safety: Public Citizen’s Health Research Group in the Courts
-Review: Part 6, Interactions of the Most Frequently Prescribed Drugs
February 1998, Vol. 4 #2
-You Saw It Here First: A Look Back at Early Warnings From Worst Pills Best Pills News
-Wait To Take This Drug: Raloxifene (Evista) for Osteoporosis: No Proof That It Reduces Fracture Risk
-Danger! Serious Problems Are Reported With New Blood Pressure Drug
-What Do We Know About St. John’s Wort?
-Review - Part 5: Interactions of the Most Frequently Prescribed Drugs in the U.S.
January 1998, Vol. 4 #1
-Bill Clinton’s Bloody Hands: New Law Puts FDA on Fast Track -- Toward 19th Century
-Review: Part 4, Interactions of the Most Frequently Prescribed Drugs in the U.S.
-Do Not Use! Troglitazone (Rezulin) for Diabetes: Its Risks Outweigh Its Benefits
-"High-K" Peril: Drugs That Can Raise Potassium Levels in Elderly People
December 1997 , Vol. 3 #12
-Do Not Use: Phen/Pro and Phen/Phen: Diet Drug Traps for the Unwary
-Calicum Channel Blockers and Breast Cancer in Postmenopausal Women
-Save Your Money! Bromfenac (Duract) - Another Nonsteroidal Anti-Inflammatory
-New Adverse Reaction Warning! Liver Toxicity and Troglitzaone (Rezulin), a New Diabetes Drug
-Review: Part 3 Interactions Associated With Frequently Prescribed Drugs
November 1997, Vol. 3 #11
-Pemoline (Cyclert) Withdrawn from the UK Market Because of Serious Liver Damage
-Review: Part 2: Drug Interactions of the Most Frequently Prescribed Drugs in the U.S.
-Caution: Drug Leaflets Distributed By Pharmacists Aren’t Necessarily Approved by the FDA
-Warning: More Life Threatening Interactions with Terfenadine (Seldane)
-Strange Names and Stranger Handwriting Often Cause Confusion About Prescription Drugs
October 1997, Vol. 3 #10
-Review: Part 1: Drug Interactions of the Most Frequently Prescribed Drugs in the U.S.
-Caution: Bupropion (Zyban) For Smoking Cessation and Bupropion (Wellbutrin) the Antidepressant Are the Same Drug
-Important New Research: Another Benefit of Treating High Blood Pressure in the Elderly With Low Dose Water Pills (Diuretics) and Beta Blockers (Atenolol, Tenormin)
-Direct to Consumer TV & Radio Ads- A boon to Drug Sales and a Windfall for Madison Avenue
-Warning for Patients: Toxicity when Oral and Topical Products Containing Diphenhydramine (Benadryl and Generics) Are Used Together in Children
-Update on Diet Drugs: FDA Announces Withdrawal of Fenfluramine (Pondimin) and Dexfenfluramine (Redux)
September 1997, Vol. 3 #9
-Warning: Dangers of "Off-label" Prescribing -Heart Valve Damage Associated with the Diet Drug Combination Fen/Phen (Fenfluramine/Phentermine)
-Warning: Life-Threatening Adverse Drug Reaction with New Asthma Drug Zafirlukast (Accolate)
-FDA Warns Consumers Not to Use Skin-Cap, A Treatment for Psoriasis
August 1997, Vol.3 #8
-Donepezil (Aricept) for Alzheimer’s: Is it any Better than Tacrine(Cognex)?
-Warning: Recall of More Dangerous Dietary Supplements
-Three FDA Blunders: Butorphanol (Stadol), Pentazocine (Talwin), and Tramadol (Ultram)
-Penciclovir (Denavir) Cream: Expensive Treatment for Cold Sores
July 1997, Vol. 3 #7
-Warning: Potentially Deadly Chomper Herbal Laxative Recalled
-Older Drugs Are Shown To Reduce Complications of High Blood Pressure
-Warning: Cancer Link with Laxatives Containing Phenolphthalein (Ex-Lax, Doxidan, Dialose)
June 1997, Vol. 3 #6
-Wait Five Years to Take this Drug: Valsartan (Diovan), the Second Angiotensin II Blocker for High Blood Pressure
-Levothyroxine (Synthroid) and the $800 Million Deception
-Drug Errors: Confusing Drug Names That Can Be Dangerous
May 1997, Vol. 3 #5
- Do Not Use: Fen/Phen - Fenfluramine (Pondimin) Combined with Phentermine (Ionamin)
- Fatal Adverse Drug Reaction Warning Lamotrigine (Lamictal) for Seizures
- Wait Five Years to Take Zafirlukast (Accolate) and Zileuton (Zyflo): Two New Drugs To Prevent Asthma Attacks
April 1997, Vol. 3 #4
- False and Misleading Promotion of the Nonsteroidal Anti-inflammatory Drug (NSAID) Nabumetone (Relafen)
- Gastrointestinal (GI) Bleeding From Nonsteroidal Anti-inflammatory Drugs (NSAIDs): Well Informed Patients May Avoid Hospitalization
- How New Drugs Are Tested and Approved
March 1997, Vol. 3 #3
- Terfenadine (Seldane) or Astemizole (Hismanal) FDA Proposes to Ban the Antihistamine Terfenadine
- Alendronate (Fosamax) and Hip Fracture - Who Benefits and How Much?
February 1997, Vol. 3 #2
- A Tragic Insulin Overdose
- Wait Five Years To Take This Drug: Trandolapril (Mavik) for High Blood Pressure
- Do Not Use: Cyclandelate (Cyclospasmol) Removing an Ineffective Drug from the Market: How Long Can It Take?
January 1997, Vol. 3 #1
- Adverse Drug Reaction Warning: Prazosin (Minipress), Terazosin (Hytrin), Doxazosin (Cardura) and Incontinence in Women
- Do Not Use: Chlormezanone (Trancopal) Discontinued Due to Serious Skin Reactions
December 1996, Vol. 2 #12
- Do Not Use: Nifedipine (Adalat and Procardia) For Emergency High Blood Pressure Lowering
- Important New Research: Risk of Serious Low Blood Sugar with Antidiabetic Drugs
- DHEA (Dehydroepiandrosterone) Safety and Effectivenss Have Not Been Proven
November 1996, Vol. 2 #11
- Warning! Ticlopidine (Ticlid) and Life-threatening Blood Disorders
- Adverse Reaction Warning! Finasteride (Proscar) and Breast Enlargement in Men
- Calcium Channel Blockers Are Overused in Elderly Heart Attack Survivors
October 1996, Vol. 2 #10
- Lethal Drug Interactions: Who is the Last Line of Defense?
- Stronger Warning! The Diet Drug Dexfenfluramine (Redux) and Primary Pulmonary Hypertension
- Benign Prostatic Hyperplasia (BPH or Enlarged Prostate): Terazosin (Hytrin) Compared with Finasteride (Proscar)
September 1996, Vol. 2 #9
- Review: Nonprescription and Prescription Sleeping Pills
- Alert: Digoxin (Lanoxin) is Still Being Overprescribed
August 1996, Vol. 2 #8
- Adverse Reaction Warning: Public Citizen Petitions FDA to Add a Warning to All Fluoroquinolone Antibiotics (Cipro, Penetrex, Maxaquin, Noroxin, Floxin)
- Cancer and High Blood Pressure Drugs: More Research on Calcium Channel Blockers
- Save Your Money - Do Not Use! Simethicone Doesn't Work for Gas or Infant Colic
July 1996, Vol. 2 #7
- Do Not Use: Dexfenfluramine (Redux): A Diet Drug Without Proven Value and Possible Serious Adverse Effects
- Do Not Use This Drug for Five Years: Glimepiride (Amaryl) - Another Drug for Non-Insulin-Dependent Diabetes Mellitus
- Warning! Calcium Channel Blockers: Risk of Gastrointestinal Bleeding in the Elderly
June 1996, Vol. 2 #6
- Alendronate (Fosamax): How Effective Is It?
- Alendronate (Fosamax) and Sever Ulceration of the Esophagus
- The Erythromycin (E-Mycin, EES) - Terfenadine (Seldane) Drug Interaction: Why the Public Needs Drug Information Now!
May 1996, Vol. 2 #5
- Do Not Take This Drug Nisoldipine - Another Calcium Channel Blocker
- More Warnings About Tramadol
- Children's Motrin Suspension for Fever: Is it Any Better than Generic Actaminophen Suspension
April 1996, Vol. 2 #4
- Review: Drug-Induced Liver Toxicity
- Acarbose (Precose) for Diabetes No Substitute for Diet and Exercise
- Stronger Warning: Liver Toxicity and Chlorzoxazone (Parafon Forte DSC, Paraflex)
March 1996, Vol. 2 #3
- Cholesterol-Lowering Drugs and Cancer
- Tylenol and Alcohol: A Dangerous Cocktail
- Losartan (Cozaar) for High Blood Pressure
February 1996, Vol. 2 #2
- Warning! Increased Risk of Parkinsonism with Metoclopramide (Reglan)
- Bronchospasm (Wheezing) and Cisapride (Propulsid)
- Adverse Reactions from Herbal Medicines
- Warning! Drug Interaction Theophylline (Slo-Bid, Theolair) and Ticlopidine (Ticlid)
January 1996, Vol. 2 #1
- New Drug Interaction Warnings for Cisapride (Propulsid)
- Warning! Hallucinations and Confusion with Tramadol (Ultram)
- What You Can Do: Finding Information About New Drugs
- Statement on Warner-Lambert Criminal Conviction and Poor Manufacturing Practices
December 1995, Vol. 1 #10
- Cholesterol-lowering Drug Probucol (Lorelco) Withdrawn from the Market
- Calcitonin-Salmon (Miacalcin) Nasal Spray for Osteoporosis: No Proof that it Reduces the Risk of Fracture
- Drug Induced Disease: Parkinson's Disease or Drug-Induced Parkinsonsim?
November 1995, Vol. 1 #9
- Widely Used Calcium Channel Blocking Drugs: Increased Risk of Heart Attack and Death
- Eight is More Than Enough: Moexipril (Univasc) For High Blood Pressure
- Drug Interaction: Lovastatin (Mevacor) and Itraconazole (Sporanox) Linked in Severe Muscle Inflammation
October 1995, Vol. 1 #8
- Drug Interactions: Ciprofloxacin (CIPRO) and Iron Supplements
- Wait 5 Years to take this Drug: Lansoprazole (Prevacid)
- New GAO Report: Prescription Drugs and the Elderly
September 1995, Vol. 1 #7
- More Research on Drug-Induced Falls: Nursing Homes
- Warning: Risk Without Benefit - Amiodarone (Cordarone) in Non-life-threatening Irregular Heart Rhythm
- Promoting Health in Developing Countries? Parke Davis Offers Free Wine with Sinutab in Peru
- Adverse Effects: Tendon Damage with the Family of Fluoroquinolone Antibiotics
August 1995, Vol. 1 #6
- Quinidine Warning: Risk of Death
- Medication Errors
- Warning: Timolol (Timoptic) Eye Drops Cause Unrecognized Breathing Problems in Older Adults
July 1995, Vol. 1 #5
- Do Not Use Glucophage (Metformin)
- Do Not Use Trental (Pentoxifylline)
- Call to Ban Common Lice/Scabies Drug: Lindane
June 1995, Vol. 1 #4
- Prescribing in Hypertension: Older Drugs are Usually Better
- Warning: Drug-Induced Falling - Increased Risk in Hospitals
May 1995, Vol. 1 #3
- Severe Neuropsychiatric Side Effects Associated with the Antimalarial Drug Mefloquine (Lariam)
- Finasteride (Proscar) For Benign Prostatic Hypertrophy
- Health Tip: Tetanus Boosters: A Timely Reminder About a Rare Persistent Danger
- Dangerous Drug Interactions with Cisapride (Propulsid)
April 1995, Vol. 1 #2
- Antidepressants with Eldepryl Can Be Fatal
- Painkiller-induced Kidney Failure
- Herbal Product and Liver Side Effects
- Dangerous Drug Interactions with the Sleeping Pill Triazolam (Halcion)
March 1995, Vol. 1 #1
- Ban this Drug: Feldene is too Risky for Arthritis Patients
- Warning: Prozac has Harmful Interaction with Dilantin (phenytoin) and other drugs
- Don't Mix Tylenol and Alcohol
- Asthma Drug Recall (Alupent) by Boehringer Ingelheim Because of Reduced
